Abuse Liability Study of Staccato Alprazolam for Inhalation in Subjects With Histories of Sedative Abuse

Trial Profile

Abuse Liability Study of Staccato Alprazolam for Inhalation in Subjects With Histories of Sedative Abuse

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2009

At a glance

  • Drugs Alprazolam (Primary) ; Alprazolam (Primary)
  • Indications Anxiety disorders; Panic disorder
  • Focus Therapeutic Use
  • Sponsors Alexza Pharmaceuticals
  • Most Recent Events

    • 12 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Mar 2009 Actual end date January 2009 added as reported by ClinicalTrials.gov.
    • 08 Jan 2009 Planned end date changed from 1 Dec 2008 to 1 Feb 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top